Navigation Links
Insight Into The Risky Health Decisions On Bird Flu

Many may appear in mind like choosing a risky vaccine, which is under experiment, or even leaving it to die, or make complaints on public// healthcare community – when a deadly avian flu attacks America.

About making tricky decisions, changes in conclusions that have made and putting ourselves as a decision maker was viewed in a new study.

The findings may help individuals who face tough health choices, and decision-makers who make choices for larger groups. It may also help illuminate situations where individuals make medical decisions that go against the advice from experts and authorities, and help guide doctors in advising patients.

In the June issue of the Journal of General Internal Medicine, a teathe University of Michiganm from Medical School and the VA Ann Arbor Healthcare System report the results of a medical decision-making study involving nearly 2,400 people of all ages and backgrounds who completed extensive online questionnaires.

Study participants were first randomly divided into four groups. People in one group of participants were asked to imagine themselves as patients in two different medical scenarios -- an experimental vaccine against a deadly flu and chemotherapy for a slow-growing cancer -- and asked to choose either to get the medical option or to take their chances without it. Each of the options carried risks and benefits, though the statistically better choice in each scenario was to get the vaccine or chemotherapy.

The remaining three groups of participants also read the same medical scenarios, but they were asked to think about the problem from different perspectives. One group put themselves in the shoes of a doctor advising a patient, another took the role of a parent deciding for a child, and a third group imagined being a medical director of a hospital making a guideline for treating many patients. All four groups made treatment choices and also reported what em otions each of those decisions provoked.

The results were striking. Only 48 percent of individuals who imagined being the patient said they would choose the flu vaccine for themselves, but 57 percent of those imagining being parents would decide to vaccinate a child, 63 percent of respondents taking on a physician role would advise a patient to get it, and 73 percent of those acting as medical directors would choose to vaccinate large numbers of patients.

The same pattern repeated for the chemotherapy scenario, with 60 percent choosing it for themselves, 72 percent choosing it for their children and 68 percent opting to advise individual patients and groups to get it.

‘It's very hard to see the big picture when faced with a tough medical decision,’ says lead author Brian Zikmund-Fisher, Ph.D. ‘We get wrapped up in our own situation, and that perspective makes us focus on certain aspects of problem and ignore others.’ It's also human nature to avoid an option that might bring immediate harm upon yourself -- even when a ‘wait and see’ approach may carry even greater risks than taking action. It's a reaction that researchers call the ‘omission tendency.’

‘Trying to step into someone else's shoes might give you a different perspective when you have a difficult health decision to make,’ Zikmund-Fisher explains. ‘If we take a moment, pause and consider the situation from a different angle, then that may help us see all the different pieces of information that are relevant. If we do that, we may end up making a different choice, but even if we don't, we can be confident that we have made an informed choice.’

The study also highlights another human tendency that arises when we're in the position of making decisions on behalf of another person: to try to do everything in our power to help them. Whether it's parents deciding for their children, a woman choosing for her incapacitated husband, or an adult choosing for an el derly parent, these kinds of decisions happen every day.

‘In such cases, the natural assumption is that the patient's doctors would make the same decision as you would, but that's not necessarily true because they're seeing the situation from a different perspective,’ says Zikmund-Fisher, a decision scientist and research investigator at the U-M Medical School's Center for Behavioral & Decision Sciences in Medicine who holds VA and U-M positions.

Just as the participants in the new study did when they put themselves in the shoes of a doctor or medical director, medical professionals may tend to choose more proactive treatment even if it carries risks, the researchers say. From their perspective, taking action is a more justifiable choice than doing nothing and accepting even greater risks. The same is true for medical directors of hospitals or insurance plans, who must make defensible, justifiable decisions for groups of patients.

The study's results also suggest that doctors should not shy away from guiding patients' choices, as some studies have suggested may be happening in this age of ‘consumer-driven’ health care. Doctors can provide a valuable perspective on a medical choice, without being paternalistic, when they present patients with information about their condition and treatment options.

The study's senior author, Peter Ubel, M.D., director of the CDBSM and a professor of internal medicine at the U-M Medical School, believes that the study sheds light on tension in the doctor/patient relationship: ‘Most people try to follow the golden rule, doing unto others as they'd do unto themselves. But in this study, people seem to be following some other rule; the platinum rule, maybe? They do differently unto others than they would do unto themselves and, for the health situations we studied, they actually made better decisions for other people than they made for themselves. If physicians think this way when talking with patients, they may end up helping patients by talking them into decisions -- good decisions -- that they otherwise would not make.’

The researchers were surprised by what they found when they tabulated the emotional responses reported by the study participants for each scenario. Interestingly, the scenarios that involved deciding for a child or a patient triggered more emotional involvement than those involving decisions for oneself. Zikmund-Fisher speculates that this may be because it's easier to summon up the potential emotional impact of making a wrenching decision for someone else than to imagine oneself in a situation that doesn't exist.

Now, the researchers are working to extend their work into studying decisions about end-of-life situations, where choices are often wrenching for families and clinicians alike. They also hope to perform studies of specific patient populations, rather than the general public sample used in the current study. In addition to Zikmund-Fisher and Ubel, the study's authors are Angela Fagerlin, Ph.D. and Brianna Sarr, B.S., of the CDBSM. The study was funded by the National Institutes of Health.

Surce: Eirekalert
'"/>




Related medicine news :

1. fMRI Offers Insight Into An Infants Brain
2. New Insight To The Role Of Peptide Signals
3. New Insight Gained For Allergic Reactions
4. Insight for Hot Flashes In Postmenopausal Women
5. New Insight In Periodontal Disease In Postmenopausal Women
6. Researchers Bring New Insight To Asthma And SABA Fills
7. Study Unveils New Insight To The Madness Of King George III
8. Study Offers Insights Into Treatment Of Rheumatoid Arthritis
9. Reindeer Provide Valuable Insights Into Sleep Disorders
10. Cure Insight for DMD
11. Insights Into Lead Pollution
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/19/2017)... LOUISVILLE, Ky. , Sept. 19, 2017   ZirMed ... and predictive analytics, today announced that it has been ranked ... the Black Book™ Rankings 2017 User Survey. ZirMed ... software solution for large hospitals and medical centers over 200 ... in Black Book,s healthcare technology user survey history. ...
(Date:9/12/2017)... N.J. , Sept. 12, 2017  Consumer reviews on the ... Hearing as the number one company for hearing aids, ranking ... and fifteen other brands. ... Embrace Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides high ...
Breaking Medicine Technology: